Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs

Charles Swanton, Michela Marani, Olivier Pardo, Patricia H. Warne, Gavin Kelly, Erik Sahai, Frédéric Elustondo, Jenny Chang, Jillian Temple, Ahmed A. Ahmed, James D. Brenton, Julian Downward, Barbara Nicke

Research output: Contribution to journalArticle

284 Scopus citations

Abstract

Cytotoxic drug resistance is a major cause of cancer treatment failure. We report an RNA interference screen to identify genes influencing sensitivity of different cancer cell types to chemotherapeutic agents. A set of genes whose targeting leads to resistance to paclitaxel is identified, many of which are involved in the spindle assembly checkpoint. Silencing these genes attenuates paclitaxel-induced mitotic arrest and induces polyploidy in the absence of drug. We also identify a ceramide transport protein, COL4A3BP or CERT, whose downregulation sensitizes cancer cells to multiple cytotoxic agents, potentiating endoplasmic reticulum stress. COL4A3BP expression is increased in drug-resistant cell lines and in residual tumor following paclitaxel treatment of ovarian cancer, suggesting that it could be a target for chemotherapy-resistant cancers.

Original languageEnglish (US)
Pages (from-to)498-512
Number of pages15
JournalCancer Cell
Volume11
Issue number6
DOIs
StatePublished - Jun 12 2007

Keywords

  • CELLCYCLE
  • CHEMBIO

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Fingerprint Dive into the research topics of 'Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs'. Together they form a unique fingerprint.

Cite this